Literature DB >> 27054030

The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Cong Zheng1, Xin-Wen Zhou1, Jian-Zhi Wang2.   

Abstract

Alzheimer's disease (AD) is one of the most common neurodegenerative disorders in the elderly. Although the mechanisms underlying AD neurodegeneration are not fully understood, it is well recognized that inflammation plays a crucial role in the initiation and/or deterioration of AD neurodegeneration. Increasing evidence suggests that different cytokines, including interleukins, TNF-α, TGF-β and IFN-γ, are actively participated in AD pathogenesis and may serve as diagnostic or therapeutic targets for AD neurodegeneration. Here, we review the progress in understanding the important role that these cytokines or neuroinflammation has played in AD etiology and pathogenesis.

Entities:  

Keywords:  Alzheimer’s disease; Cytokines; IFN-γ; Interleukins; TGF-β; TNF-α

Year:  2016        PMID: 27054030      PMCID: PMC4822284          DOI: 10.1186/s40035-016-0054-4

Source DB:  PubMed          Journal:  Transl Neurodegener        ISSN: 2047-9158            Impact factor:   8.014


  167 in total

1.  Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.

Authors:  Christine M Sandiego; Jean-Dominique Gallezot; Brian Pittman; Nabeel Nabulsi; Keunpoong Lim; Shu-Fei Lin; David Matuskey; Jae-Yun Lee; Kevin C O'Connor; Yiyun Huang; Richard E Carson; Jonas Hannestad; Kelly P Cosgrove
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-18       Impact factor: 11.205

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells.

Authors:  K McQuillan; Marina A Lynch; Kingston H G Mills
Journal:  Brain Behav Immun       Date:  2010-01-12       Impact factor: 7.217

Review 4.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

5.  Amyloid β oligomers induce interleukin-1β production in primary microglia in a cathepsin B- and reactive oxygen species-dependent manner.

Authors:  Jun Taneo; Takumi Adachi; Aiko Yoshida; Kunio Takayasu; Kazuhiko Takahara; Kayo Inaba
Journal:  Biochem Biophys Res Commun       Date:  2015-02-11       Impact factor: 3.575

6.  IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice.

Authors:  Meng-Shan Tan; Jin-Tai Yu; Teng Jiang; Xi-Chen Zhu; Hua-Shi Guan; Lan Tan
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 7.  The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.

Authors:  Myles R Minter; Juliet M Taylor; Peter J Crack
Journal:  J Neurochem       Date:  2015-11-18       Impact factor: 5.372

Review 8.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

Review 9.  Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.

Authors:  Frederic Brosseron; Marius Krauthausen; Markus Kummer; Michael T Heneka
Journal:  Mol Neurobiol       Date:  2014-02-25       Impact factor: 5.590

10.  Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology.

Authors:  Kuti Baruch; Neta Rosenzweig; Alexander Kertser; Aleksandra Deczkowska; Alaa Mohammad Sharif; Amit Spinrad; Afroditi Tsitsou-Kampeli; Ayelet Sarel; Liora Cahalon; Michal Schwartz
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

View more
  71 in total

1.  Necroptosis activation in Alzheimer's disease.

Authors:  Antonella Caccamo; Caterina Branca; Ignazio S Piras; Eric Ferreira; Matthew J Huentelman; Winnie S Liang; Ben Readhead; Joel T Dudley; Elizabeth E Spangenberg; Kim N Green; Ramona Belfiore; Wendy Winslow; Salvatore Oddo
Journal:  Nat Neurosci       Date:  2017-07-24       Impact factor: 24.884

Review 2.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

3.  CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation.

Authors:  Debanjana Chakravarty; Fareeha Saadi; Soumya Kundu; Abhishek Bose; Reas Khan; Kimberly Dine; Lawrence C Kenyon; Kenneth S Shindler; Jayasri Das Sarma
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

4.  Systemic inflammatory markers in relation to cognitive function and measures of brain atrophy: a Mendelian randomization study.

Authors:  Jiao Luo; Saskia le Cessie; Gerard Jan Blauw; Claudio Franceschi; Raymond Noordam; Diana van Heemst
Journal:  Geroscience       Date:  2022-06-11       Impact factor: 7.713

Review 5.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 6.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

Review 7.  The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease.

Authors:  Antero Salminen; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2018-05-19       Impact factor: 9.261

8.  Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.

Authors:  Isabel Barroeta-Espar; Laura D Weinstock; Beatriz G Perez-Nievas; Avery C Meltzer; Michael Siao Tick Chong; Ana C Amaral; Melissa E Murray; Krista L Moulder; John C Morris; Nigel J Cairns; Joseph E Parisi; Val J Lowe; Ronald C Petersen; Julia Kofler; Milos D Ikonomovic; Oscar López; William E Klunk; Richard P Mayeux; Matthew P Frosch; Levi B Wood; Teresa Gomez-Isla
Journal:  Neurobiol Dis       Date:  2018-10-15       Impact factor: 5.996

Review 9.  Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Authors:  Fangda Leng; Paul Edison
Journal:  Nat Rev Neurol       Date:  2020-12-14       Impact factor: 42.937

10.  Extracellular signal-regulated kinase regulates microglial immune responses in Alzheimer's disease.

Authors:  Michael J Chen; Supriya Ramesha; Laura D Weinstock; Tianwen Gao; Lingyan Ping; Hailian Xiao; Eric B Dammer; Duc D Duong; Allan I Levey; James J Lah; Nicholas T Seyfried; Levi B Wood; Srikant Rangaraju
Journal:  J Neurosci Res       Date:  2021-03-17       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.